$KRMD
KORU Medical Systems, Inc. Stock $krmd

$krmd Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000116169722000377 Filed on August 03, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$7.760M	$6.547M	$6.244M
YoY Change	28.47%	18.42%	15.0%
Cost Of Revenue	$3.438M	$3.200M	$2.622M
YoY Change	35.1%	38.07%	19.18%
Gross Profit	$4.322M	$3.346M	$3.622M
YoY Change	23.65%	4.24%	12.15%
Gross Profit Margin	55.7%	51.11%	58.01%
Selling, General & Admin	$4.825M	$5.530M	$5.491M
YoY Change	23.67%	35.34%	10.04%
% of Gross Profit	111.64%	165.26%	151.59%
Research & Development	$862.1K	$1.304M	$1.148M
YoY Change	7.77%	236.99%	237.75%
% of Gross Profit	19.95%	38.96%	31.7%
Depreciation & Amortization	$164.3K	$125.9K	$109.3K
YoY Change	41.76%	6.31%	-8.96%
% of Gross Profit	3.8%	3.76%	3.02%
Operating Expenses	$5.852M	$6.960M	$6.749M
YoY Change	21.46%	51.59%	24.06%
Operating Profit	-$1.529M	-$3.613M	-$3.127M
YoY Change	15.69%	161.65%	41.47%
Interest Expense	$32.42K	-$18.14K	-$8.600K
YoY Change	-420.36%	-262.11%	-14.0%
% of Operating Profit
Other Income/Expense, Net	$32.42K	-$18.14K	-$8.598K
YoY Change	-429.19%	-262.11%
Pretax Income	-$1.497M	-$3.632M	-$3.135M
YoY Change	12.4%	165.11%	41.22%
Income Tax	-$271.5K	-$710.3K	-$597.6K
% Of Pretax Income
Net Earnings	-$1.226M	-$2.921M	-$2.538M
YoY Change	12.05%	159.78%	98.84%
Net Earnings / Revenue	-15.79%	-44.62%	-40.64%
Basic Earnings Per Share	-$0.03	-$0.07	-$0.06
Diluted Earnings Per Share	-$0.03	-$0.07	-$56.81K
COMMON SHARES
Basic Shares Outstanding	45.03M shares	44.92M shares	44.67M shares
Diluted Shares Outstanding	45.04M shares	44.92M shares	44.67M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.44M	$18.27M	$22.58M
YoY Change	-37.33%	-31.17%	-15.66%
Cash & Equivalents	$16.44M	$18.27M	$22.58M
Short-Term Investments
Other Short-Term Assets	$1.661M	$1.166M	$1.511M
YoY Change	24.22%	152.56%	118.96%
Inventory	$6.884M	$6.772M	$6.018M
Prepaid Expenses	$1.661M	$1.166M
Receivables	$5.070M	$4.085M	$3.145M
Other Receivables	$686.1K	$680.8K	$680.1K
Total Short-Term Assets	$30.74M	$30.97M	$33.93M
YoY Change	-18.37%	-16.62%	-13.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.319M	$2.823M	$6.073M
YoY Change	157.05%	121.07%	346.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$88.77K	$88.77K	$2.628M
YoY Change	-94.4%	-93.41%	141.14%
Total Long-Term Assets	$11.92M	$11.49M	$9.496M
YoY Change	222.5%	232.29%	189.52%
TOTAL ASSETS
Total Short-Term Assets	$30.74M	$30.97M	$33.93M
Total Long-Term Assets	$11.92M	$11.49M	$9.496M
Total Assets	$42.67M	$42.46M	$43.43M
YoY Change	3.16%	4.59%	2.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.366M	$2.390M	$1.268M
YoY Change	-1.43%	137.64%	-33.96%
Accrued Expenses	$2.569M	$1.974M	$3.073M
YoY Change	2.71%	-14.33%	17.75%
Deferred Revenue
YoY Change
Short-Term Debt	$644.7K	$0.00	$255.6K
YoY Change	-4.22%
Long-Term Debt Due	$64.47K	$66.50K
YoY Change	15624.39%	6356.31%
Total Short-Term Liabilities	$6.167M	$5.730M	$4.713M
YoY Change	35.26%	73.06%	4.03%
LONG-TERM LIABILITIES
Long-Term Debt	$265.5K	$282.0K	$0.00
YoY Change
Other Long-Term Liabilities	$3.741M	$3.828M	$3.914M
YoY Change		15829.67%	6423.2%
Total Long-Term Liabilities	$4.007M	$4.110M	$3.914M
YoY Change		17003.04%	6423.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.167M	$5.730M	$4.713M
Total Long-Term Liabilities	$4.007M	$4.110M	$3.914M
Total Liabilities	$10.17M	$9.840M	$8.627M
YoY Change	123.12%	195.04%	87.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.594M	-$6.369M
YoY Change
Common Stock	$43.93M	$42.83M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.844M	$3.844M
YoY Change
Treasury Stock Shares	3.421M shares	3.421M shares
Shareholders Equity	$32.49M	$32.62M	$34.80M
YoY Change
Total Liabilities & Shareholders Equity	$42.67M	$42.46M	$43.43M
YoY Change	3.16%	4.59%	2.5%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.226M	-$2.921M	-$2.538M
YoY Change	12.05%	159.78%	98.84%
Depreciation, Depletion And Amortization	$164.3K	$125.9K	$109.3K
YoY Change	41.76%	6.31%	-8.96%
Cash From Operating Activities	-$2.116M	-$2.873M	-$1.752M
YoY Change	156.07%	1629.3%	-32.87%
INVESTING ACTIVITIES
Capital Expenditures	-$648.9K	-$1.176M	-$752.6K
YoY Change	328.69%	1676.78%	584.18%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$648.9K	-$1.176M	-$752.6K
YoY Change	328.72%	1651.91%	652.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	940.3K	-262.2K	-253.0K
YoY Change	39.81%	7349.43%	-111.66%
NET CHANGE
Cash From Operating Activities	-2.116M	-2.873M	-1.752M
Cash From Investing Activities	-648.9K	-1.176M	-752.6K
Cash From Financing Activities	940.3K	-262.2K	-253.0K
Net Change In Cash	-1.824M	-4.312M	-2.758M
YoY Change	498.01%	1720.74%	410.67%
FREE CASH FLOW
Cash From Operating Activities	-$2.116M	-$2.873M	-$1.752M
Capital Expenditures	-$648.9K	-$1.176M	-$752.6K
Free Cash Flow	-$1.467M	-$1.697M	-$999.5K
YoY Change	117.35%	1597.86%	-60.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000704440
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2021Q4	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross		usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	krmd	Payments On Indebtedness PaymentsOnIndebtedness		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	krmd	Common Stock Issuance As Settlement For Litigation CommonStockIssuanceAsSettlementForLitigation		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	krmd	Lessor Operating Lease Option To Terminate1 LessorOperatingLeaseOptionToTerminate1	P5Y
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet		usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y2M12D
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P0Y7M6D
CY2022Q2	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P5Y
CY2021Q4	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P0Y0M0D
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-12305
	dei	Entity Registrant Name EntityRegistrantName	KORU MEDICAL SYSTEMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3044880
	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Corporate Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Mahwah
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07430
	dei	City Area Code CityAreaCode	(845)
	dei	Local Phone Number LocalPhoneNumber	469-2042
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Repro Med Systems, Inc.
	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	KRMD
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45033053	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2022Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3420502	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18265552	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25334889	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24471	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24471	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4084762	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3592886	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	6771514	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	6106338	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	680796	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	718220	usd
CY2022Q2	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	349153	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3249323	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	66503	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	363030	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95553	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5730134	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4791976	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	281958	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3827900	usd
CY2022Q2	us-gaap	Liabilities Liabilities	9839992	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4791976	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1165668	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1568821	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	30968292	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	37321154	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2823090	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1106445	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	294301	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	263729	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	791781	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	808813	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4190931	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95553	usd
CY2022Q2	krmd	Finance Lease Right Of Use Asset Amortization1 FinanceLeaseRightOfUseAssetAmortization1	5918	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1941254	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	88772	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19812	usd
CY2022Q2	us-gaap	Assets Assets	42461342	usd
CY2021Q4	us-gaap	Assets Assets	41293031	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2389862	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1227533	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1974196	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2709704	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	508583	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	240501	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	90000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	696042	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	160603	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48407619	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48044162	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44987117	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6739977	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3594343	usd
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44623660	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	484076	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	480441	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	42349760	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	40774245	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	3420502	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	3420502	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	3843562	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3843562	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6368924	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-910069	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	32621350	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	36501055	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42461342	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41293031	usd
CY2022Q2	us-gaap	Revenues Revenues	6546628	usd
CY2021Q2	us-gaap	Revenues Revenues	5528174	usd
	us-gaap	Revenues Revenues	12790958	usd
	us-gaap	Revenues Revenues	10959125	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3200455	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2317990	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5822480	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4517087	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	3346173	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	3210184	usd
	us-gaap	Gross Profit GrossProfit	6968478	usd
	us-gaap	Gross Profit GrossProfit	6442038	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5530022	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4085945	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11021235	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9078774	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1303731	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	386878	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2452086	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	723719	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	125882	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118415	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	235134	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	233888	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	6959635	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	4591238	usd
	us-gaap	Operating Expenses OperatingExpenses	13708455	usd
	us-gaap	Operating Expenses OperatingExpenses	10036381	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3613462	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1381054	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44795625	shares
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1369865	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-21705	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6766714	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3588364	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44226936	shares
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1239	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28840	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-14478	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	736	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3566	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9950	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2103	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19721	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18139	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11189	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-26737	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5979	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3631601	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-710260	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-245316	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1307859	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1187677	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2921341	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1124549	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5458855	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2400687	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44921870	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44489853	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44795625	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44226936	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44921870	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44489853	shares
	us-gaap	Net Income Loss NetIncomeLoss	-5458855	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2400687	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1579151	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1339356	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	235134	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	233888	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4625314	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2776150	usd
	krmd	Issuance Of Common Stock Compensation IssuanceOfCommonStockCompensation	258005	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1308069	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1201956	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	736	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	454452	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4446	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	665176	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	732978	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-334193	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-346227	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	150501	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1162329	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	380733	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	535438	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	103196	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-735508	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-838747	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1915289	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	152223	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	9065	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	13540	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	23978	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1928829	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-167136	usd
	krmd	Payments On Indebtedness PaymentsOnIndebtedness	508583	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1230000	usd
	krmd	Common Stock Issuance As Settlement For Litigation CommonStockIssuanceAsSettlementForLitigation	938094	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6611	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1616	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-515194	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2166478	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7069337	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-776808	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25334889	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27315286	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18265552	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26538478	usd
	us-gaap	Interest Paid Net InterestPaidNet	6204	usd
	us-gaap	Interest Paid Net InterestPaidNet	47	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	850	usd
	krmd	Issuance Of Common Stock Compensation IssuanceOfCommonStockCompensation	153446	usd
	us-gaap	Stock Issued1 StockIssued1	938094	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	36501055	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	142500	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	524670	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	170386	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2537514	usd
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34801097	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	115505	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3827900	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4190930	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	70917	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	527736	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	231511	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-133158	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2921341	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	32621350	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	36156979	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56250	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	677934	usd
CY2021Q1	krmd	New Issuance Litigation Settlement Amount Issuance NewIssuanceLitigationSettlementAmountIssuance	938094	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1230000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1276138	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	37783119	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	97196	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	441841	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	66135	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1124549	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	37263742	usd
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
	us-gaap	Lease Cost LeaseCost	317870	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2921341	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1124549	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5458855	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2400687	usd
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q2	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	44921870	shares
CY2021Q2	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	44489853	shares
	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	44795625	shares
	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	44226936	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zVlMAWhzeVQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_864_zIwbeAnqfiWd">USE OF ESTIMATES IN THE FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to asset lives, valuation allowances, inventory valuation, and accruals.</p>
	us-gaap	Lease Cost LeaseCost	143727	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5918	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	95553	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	355071	usd
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	794	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5918	usd
	krmd	Schedule Of Net Sales By Geography ScheduleOfNetSalesByGeography	<p id="xdx_895_ecustom--ScheduleOfNetSalesByGeography_zHGHgBfnoo36" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span>The following table summarizes net sales by geography for the three and six months ended June 30, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_8B1_z7C7RPyPw1zb" style="display: none; visibility: hidden">Schedule of net sales by geography</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><b>Three Months Ended June 30,</b></td> <td> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><b>Six Months Ended June 30,</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2022</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2021</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2022</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2021</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 94.75pt"><b>Sales</b></td> <td style="width: 8.65pt"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 18.8pt"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 0.25in"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 18.8pt"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 8.6pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td style="padding-left: 0.2in">Domestic</td> <td> </td> <td>$</td> <td id="xdx_987_eus-gaap--Revenues_c20220401__20220630__srt--StatementGeographicalAxis__country--US_zGz167UtERg2" style="text-align: right" title="Revenues">5,512,173</td> <td> </td> <td>$</td> <td id="xdx_98B_eus-gaap--Revenues_c20210401__20210630__srt--StatementGeographicalAxis__country--US_zQxXBIecwAmk" style="text-align: right">4,645,770</td> <td> </td> <td>$</td> <td id="xdx_98B_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--US_zBEWFDItBf66" style="text-align: right">10,813,561</td> <td> </td> <td>$</td> <td id="xdx_982_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--US_zM41di0Yhoj5" style="text-align: right">9,092,559</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.2in">International</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--Revenues_c20220401__20220630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zNwzizLmLntf" style="border-bottom: black 1pt solid; text-align: right">1,034,455</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98C_eus-gaap--Revenues_c20210401__20210630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zujRR5PfI4sb" style="border-bottom: black 1pt solid; text-align: right">882,404</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98A_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zEmCyRpmh3b5" style="border-bottom: black 1pt solid; text-align: right">1,977,397</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_984_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zlIgVxKrsVkh" style="border-bottom: black 1pt solid; text-align: right">1,866,566</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td><b>Total</b></td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_986_eus-gaap--Revenues_c20220401__20220630_zoc8PwKe1Sob" style="border-bottom: black 2.25pt double; text-align: right">6,546,628</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_983_eus-gaap--Revenues_c20210401__20210630_zV2q530MHKM8" style="border-bottom: black 2.25pt double; text-align: right">5,528,174</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98B_eus-gaap--Revenues_c20220101__20220630_zQrHjNsOlBX5" style="border-bottom: black 2.25pt double; text-align: right">12,790,958</td> <td style="border-bottom: white 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_986_eus-gaap--Revenues_c20210101__20210630_ztdPmQ0u6ls1" style="border-bottom: black 2.25pt double; text-align: right">10,959,125</td> <td> </td></tr> </table>
CY2022Q2	us-gaap	Revenues Revenues	6546628	usd
CY2021Q2	us-gaap	Revenues Revenues	5528174	usd
	us-gaap	Revenues Revenues	12790958	usd
	us-gaap	Revenues Revenues	10959125	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	12725	usd
	krmd	Accounting Pronouncements Not Yet Adopted AccountingPronouncementsNotYetAdopted	<p id="xdx_84E_ecustom--AccountingPronouncementsNotYetAdopted_zPrK8RkZVHid" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_866_zTzBuQxDorvl">ACCOUNTING PRONOUNCEMENTS NOT YET ADOPTED</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In June 2016, the FASB issued ASU No. 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i>, which amends guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities. For assets held at amortized cost basis, Topic 326 eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available for sale debt securities, credit losses should be measured in a manner similar to current GAAP, however Topic 326 will require that credit losses be presented as an allowance rather than as a write-down. This ASU affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. The amendments affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is assessing the impact of the adoption of the ASU on its financial statements, disclosure requirements and methods of adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In March 2020, the FASB issued ASU No. 2020-04, <i>Reference Rate Reform (Topic 848)</i>, which provided elective amendments for entities that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments may be applied to impacted contracts and hedges prospectively through December 31, 2022. The Company is currently evaluating the impact this guidance will have on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p>
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1589	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	5918	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	-12725	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	239582	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	75290	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z9njQbOlhBqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_869_zGoOn1Wj5Gij">RECLASSIFICATION</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain reclassifications have been made to conform prior period data to the current presentation. These reclassifications had no effect on reported net income.</p>
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5321044	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3418479	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2497954	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2312034	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2823090	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1106445	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	600000	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1000000.0	usd
CY2022Q2	us-gaap	Depreciation Depreciation	104560	usd
CY2021Q2	us-gaap	Depreciation Depreciation	100564	usd
	us-gaap	Depreciation Depreciation	198644	usd
	us-gaap	Depreciation Depreciation	200967	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	28579	usd
CY2021Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	33548	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	78288	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	68437	usd
CY2021Q1	krmd	Nonemployee Services Transaction Cost NonemployeeServicesTransactionCost	75000	shares
CY2022Q2	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	160000	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	295000	shares
CY2022Q2	krmd	Stock Issued StockIssued	49600	shares
	krmd	Stock Issued StockIssued	97100	shares
CY2022Q2	us-gaap	Lease Cost LeaseCost	189719	usd
CY2021Q3	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	Monthly payments were due on the first of each month beginning August 1, 2021 through June 1, 2022.
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	161140	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	37369	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95553	usd
CY2021Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	19	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	47	usd
CY2022Q2	krmd	Finance Lease Cost FinanceLeaseCost	5918	usd
CY2021Q2	krmd	Finance Lease Cost FinanceLeaseCost	813	usd
	krmd	Finance Lease Cost FinanceLeaseCost	5918	usd
	krmd	Finance Lease Cost FinanceLeaseCost	1636	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	181544	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	70363	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6611	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1616	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4190931	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95553	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	363030	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	349153	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	66503	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	281958	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	348461	usd
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0404	pure
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0475	pure
CY2022Q2	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.0425	pure
CY2021Q4	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.0475	pure
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	79329	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	273928	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	39664	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	499503	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	79329	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	499503	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	499503	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	79329	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	499503	usd
CY2022Q2	krmd	Finance Lease Liability Payments Due Year Six FinanceLeaseLiabilityPaymentsDueYearSix	79329	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2830518	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	33052	usd
CY2022Q2	krmd	Lessee Operating Lease Liability Payments Due Total LesseeOperatingLeaseLiabilityPaymentsDueTotal	5102458	usd
CY2022Q2	krmd	Lessee Financing Lease Lease Liability Payments Due Total LesseeFinancingLeaseLeaseLiabilityPaymentsDueTotal	390032	usd
CY2022Q2	krmd	Lessee Operating Lease Imputed Interest LesseeOperatingLeaseImputedInterest	911528	usd
CY2022Q2	krmd	Lessee Financing Lease Imputed Interest LesseeFinancingLeaseImputedInterest	41571	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4190930	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	348461	usd

Files In Submission

Name	View Source	Status
0001161697-22-000377-index-headers.html	Edgar Link	pending
0001161697-22-000377-index.html	Edgar Link	pending
0001161697-22-000377.txt	Edgar Link	pending
0001161697-22-000377-xbrl.zip	Edgar Link	pending
ex_10-1.htm	Edgar Link	pending
ex_10-2.htm	Edgar Link	pending
ex_10-3.htm	Edgar Link	pending
ex_31-1.htm	Edgar Link	pending
ex_31-2.htm	Edgar Link	pending
ex_32-1.htm	Edgar Link	pending
ex_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form_10-q.htm	Edgar Link	pending
form_10-q_htm.xml	Edgar Link	completed
krmd-20220630.xsd	Edgar Link	pending
krmd-20220630_cal.xml	Edgar Link	unprocessable
krmd-20220630_def.xml	Edgar Link	unprocessable
krmd-20220630_lab.xml	Edgar Link	unprocessable
krmd-20220630_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KRMD
KORU Medical Systems, Inc. Stock $krmd

2022 Q3 Form 10-Q Financial Statement

#000116169722000377 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRMD KORU Medical Systems, Inc. Stock $krmd

2022 Q3 Form 10-Q Financial Statement

#000116169722000377 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRMD
KORU Medical Systems, Inc. Stock $krmd